Evidence map›Paper›PMID 22922464›Full record

ArticleThe EMBO journal2012

Bromodomain-dependent stage-specific male genome programming by Brdt.

Jonathan Gaucher, Fayçal Boussouar, Emilie Montellier, Sandrine Curtet, Thierry Buchou, Sarah Bertrand, Patrick Hery, Sylvie Jounier, Arnaud Depaux, Anne-Laure Vitte and 10 more

Abstract read
In one paragraph

Article in The EMBO journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Jonathan GaucherINSERM, U823, Université Joseph Fourier-Grenoble 1, Institut Albert Bonniot, Grenoble, France.
Fayçal Boussouar
Emilie Montellier
Sandrine Curtet
Thierry Buchou
Sarah Bertrand
Patrick Hery
Sylvie Jounier
Arnaud Depaux
Anne-Laure Vitte
Philippe Guardiola
Karin Pernet
Alexandra Debernardi
Fabrice Lopez
Hélène Holota
Jean Imbert
Debra J Wolgemuth
Matthieu Gérard
Sophie Rousseaux
Saadi Khochbin

Funding

Function of the Bromodomain Protein Brdt in SpermatogenesisR01GM081767 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WOLGEMUTH, DEBRA J. · 2008 to 2016
$2.9M
NIGMS NIH HHS R01 GM081767
6 · The paper itself

Abstract

Male germ cell differentiation is a highly regulated multistep process initiated by the commitment of progenitor cells into meiosis and characterized by major chromatin reorganizations in haploid spermatids. We report here that a single member of the double bromodomain BET factors, Brdt, is a master regulator of both meiotic divisions and post-meiotic genome repackaging. Upon its activation at the onset of meiosis, Brdt drives and determines the developmental timing of a testis-specific gene expression program. In meiotic and post-meiotic cells, Brdt initiates a genuine histone acetylation-guided programming of the genome by activating essential genes and repressing a 'progenitor cells' gene expression program. At post-meiotic stages, a global chromatin hyperacetylation gives the signal for Brdt's first bromodomain to direct the genome-wide replacement of histones by transition proteins. Brdt is therefore a unique and essential regulator of male germ cell differentiation, which, by using various domains in a developmentally controlled manner, first drives a specific spermatogenic gene expression program, and later controls the tight packaging of the male genome.

Indexed as

AnimalsBromodomain Containing ProteinsGene Expression ProfilingGenomeHistone AcetyltransferasesHistonesMaleMeiosisMiceNuclear ProteinsSpermatogenesisSpermatozoaBRDT protein, mouseBromodomain Containing ProteinsHistone AcetyltransferasesHistonesNuclear Proteins

Identifiers

PMID22922464
PMCPMC3463845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.